Cargando…
Mifepristone combined with ethacridine lactate for third-trimester stillbirth induction: a 5-year experience from Shanghai
OBJECTIVE: To review and analyze the efficacy and safety of mifepristone combined with ethacridine lactate for induction of stillbirth in the third trimester. METHODS: All patients with stillbirth in late pregnancy (≥ 28 weeks) in a university-affiliated maternity center from October 2016 to Septemb...
Autores principales: | Xue, Rui-Hong, Li, Juan, Yao, Yong-Li, Huang, Run-Jie, Ma, Jue, Zhang, Lin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9597990/ https://www.ncbi.nlm.nih.gov/pubmed/36289479 http://dx.doi.org/10.1186/s12884-022-05104-0 |
Ejemplares similares
-
Spectrophotometric determination of ethacridine lactate in infusion
por: Jain, Pritam S., et al.
Publicado: (2011) -
Antibacterial Properties of Ethacridine Lactate and Sulfmethoxazole Loaded Functionalized Graphene Oxide Nanocomposites
por: Jabri, Tooba, et al.
Publicado: (2023) -
Risk factors and incidence of third trimester stillbirths in China
por: Hu, Ying, et al.
Publicado: (2021) -
Development and validation of RP-HPLC method for estimation of ethacridine lactate in bulk and in pharmaceutical formulation
por: Jain, P. S., et al.
Publicado: (2011) -
Extreme temperature increases the risk of stillbirth in the third trimester of pregnancy
por: Yang, Hsiao-Yu, et al.
Publicado: (2022)